Comparison of Oncologic Outcomes of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (ddMVAC) with Gemcitabine and Cisplatin (GC) as Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis

Comparison of Oncologic Outcomes of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (ddMVAC) with Gemcitabine and Cisplatin (GC) as Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis

Platinum-based neoadjuvant chemotherapy (NAC) is widely used for treating muscle-invasive bladder cancer (MIBC). A systematic review was performed following PRISMA guidelines. PubMed, Embase, and the Cochrane Library were searched up to December 2020. We conducted a meta-analysis to compare the onco...

Full description

Bibliographic Details
Main Authors: Doo Yong Chung, Dong Hyuk Kang, Jong Won Kim, Jee Soo Ha, Do Kyung Kim, Kang Su Cho
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
bladder cancer
neoadjuvant chemotherapy
gemcitabine
cisplatin
dose-dense MVAC
Online Access:https://www.mdpi.com/2072-6694/13/11/2770

Internet

https://www.mdpi.com/2072-6694/13/11/2770

Similar Items